ESPR Past Earnings image   This ESPR past earnings page last updated 11/3/2022
ESPR Past Earnings
PeriodPast Earnings DateGAAP
Q3 202211/1/2022-0.810
Q2 20228/2/2022-1.050
Q1 20225/3/2022-0.930
Q4 20212/22/2022-1.770
Q3 202111/2/2021-2.620
Q2 20218/3/2021-1.670
Q1 20215/4/2021-3.500
Q4 20202/23/2021-3.890
Q3 202011/2/2020-3.070
Q2 20208/10/20204.320
Q1 20205/6/2020-2.840
Q4 20192/27/2020-2.260
Q3 201911/6/2019-2.520
Q2 20198/8/2019-2.010
Q1 20195/8/20193.070
Q4 20182/28/2019-2.24
Q3 201811/1/2018-1.86
Q2 20188/2/2018-1.71
Q1 20185/2/2018-1.73
Q4 20172/20/2018-1.44
Q3 201711/7/2017-1.86
Q2 20178/8/2017-1.92
Q1 20175/4/2017-1.8
Q4 20162/22/2017-1.29
Q3 201611/3/2016-0.77
Q2 20168/4/2016-0.62
Q1 20165/4/2016-0.65
Q4 20152/25/2016-0.58
Q3 201511/5/2015-0.57
Q2 20158/6/2015-0.55
Q1 20155/7/2015-0.56
Q4 20143/5/2015-0.49
Q3 201411/10/2014-0.64
Q2 20148/12/2014-0.6
Q1 20145/12/2014-0.51
Q4 20133/5/2014-0.63
Q3 201311/6/2013-0.34
Q2 20138/12/2013-19.82
Q1 20136/12/2013-0.54
ESPR Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/1/20220.02B
Q2 20228/2/20220.02B
Q1 20225/3/20220.02B
Q4 20212/22/20220.02B
Q3 202111/2/20210.01B
Q2 20218/3/20210.04B
Q1 20215/4/20210.01B
Q4 20202/23/20210.01B
Q3 202011/2/20200.00B
Q2 20208/10/20200.21B
Q1 20205/6/20200.00B
Q4 20192/27/20200.00B
Q3 201911/6/20190.00B
Q2 20198/8/20190.00B
Q1 20195/8/20190.15B
Q4 20182/28/2019NA
Q3 201811/1/2018NA
Q2 20188/2/2018NA
Q1 20185/2/2018NA
Q4 20172/20/2018NA
Q3 201711/7/2017NA
Q2 20178/8/2017NA
Q1 20175/4/2017NA
Q4 20162/22/2017NA
Q3 201611/3/2016NA
Q2 20168/4/2016NA
Q1 20165/4/2016NA
Q4 20152/25/2016NA
Q3 201511/5/2015NA
Q2 20158/6/2015NA
Q1 20155/7/2015NA
Q4 20143/5/2015NA
Q3 201411/10/2014NA
Q2 20148/12/2014NA
Q1 20145/12/2014NA
Q4 20133/5/2014NA
Q3 201311/6/2013NA
Q2 20138/12/2013NA
Q1 20136/12/2013NA
Quotes delayed 20 minutes

Email EnvelopeFree ESPR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Esperion Therapeutics (ESPR) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ETNB Past Earnings
ETON Past Earnings
ETTX Past Earnings
EVFM Past Earnings
EVLO Past Earnings
EVOK Past Earnings
EW Past Earnings
EWTX Past Earnings
EXAS Past Earnings
EXEL Past Earnings

ESPR Past Earnings Q&A

What was the best and worst ESPR past earnings results?
For Esperion Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest ESPR past earnings result in our data set was 4.320/share posted in Q2 2020, while the lowest was in Q2 2013 when ESPR posted -19.82/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2020 when ESPR reported 0.21B in revenue, while the quarter with the lowest revenue in our data set was Q4 2018 at NA of revenue.

  Suggested answer: There are 39 ESPR past earnings results in our data set.

On this page we presented the ESPR past earnings date information for Esperion Therapeutics. Reviewing that ESPR Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2020, when ESPR posted gaap of 4.320/share. Meanwhile the lowest ESPR past earnings result was in Q2 2013, when ESPR posted gaap of -19.82/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2020 when ESPR reported 0.21B in revenue, while the smallest revenue quarter was Q4 2018 when ESPR reported NA in revenue.

Any self directed investor doing their due diligence on ESPR or any other given stock can benefit from researching all of the Esperion Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you to make it easy for investors to investigate Esperion Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ESPR. Thanks for visiting, and the next time you need to research ESPR past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Funds Holding PCYC, WAAS Videos, Pfizer Average Annual Return.


ESPR Past Earnings | | Copyright © 2020 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.